GSTM1 and chronic kidney disease: We used PICOS to formulate our eligibility criteria: P (Patients): chronic kidney disease in hemodialysis patients; I (Intervention): Vitamin D supplementation; C (Control): None; O (Outcome): Effect of Vitamin D supplementation on Hb levels; S (Studies): Observational studies and Randomized Controlled Trials.